Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Brian W Dymock & Cheng Shang See. (2013) Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012. Expert Opinion on Therapeutic Patents 23:4, pages 449-501.
Read now
Read now
Maurizio Cutolo & Marianna Meroni. (2013) Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis. Journal of Inflammation Research 6, pages 129-137.
Read now
Read now
Hao Wu, Min Huang, Peng Cao, Tongshan Wang, Yongqian Shu & Ping Liu. (2012) MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation. Cancer Biology & Therapy 13:5, pages 281-288.
Read now
Read now
Fang Zhou. (2009) Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation. International Reviews of Immunology 28:3-4, pages 239-260.
Read now
Read now
Articles from other publishers (32)
Ricardo J. Antonia, Eveliina Karelehto, Kan Toriguchi, Mary Matli, Robert S. Warren, Lawrence M. Pfeffer & David B. Donner. (2022)
STAT3
regulates inflammatory cytokine production downstream of
TNFR1
by inducing expression of
TNFAIP3
/
A20
. Journal of Cellular and Molecular Medicine 26:16, pages 4591-4601.
Crossref
Crossref
Deng Chen, Ting-Xuan Tang, Hai Deng, Xiang-Ping Yang & Zhao-Hui Tang. (2021) Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis. Frontiers in Immunology 12.
Crossref
Crossref
Naeem Khan, Yongmei Hu, Clifford A. Lowell & Thomas L. Rothstein. (2021) Signal Integration by Translocation and Phosphorylation of PKCδ in the B Cell Alternate Pathway. The Journal of Immunology 207:9, pages 2288-2296.
Crossref
Crossref
Brigitte Bauvois, Elodie Pramil, Ludovic Jondreville, Claire Quiney, Florence Nguyen-Khac & Santos A. Susin. (2021) Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway. Biomedicines 9:2, pages 188.
Crossref
Crossref
Yeon-Joo Yoo, Seong-Eun Huh, Yumi Kim & Hyeung-Jin Jang. (2019) Anti-cancer Activity of Boswellia Carterii Extract Alters the Stress Functional Gene Expression in the Pancreatic Cancer Cell. BioChip Journal 13:2, pages 191-201.
Crossref
Crossref
Yue Yang, Ronge Xing, Song Liu, Yukun Qin, Kecheng Li, Huahua Yu & Pengcheng Li. (2019) Hydroxypropyltrimethyl ammonium chloride chitosan activates RAW 264.7 macrophages through the MAPK and JAK-STAT signaling pathways. Carbohydrate Polymers 205, pages 401-409.
Crossref
Crossref
Dongdong Wang, Pavel Uhrin, Andrei Mocan, Birgit Waltenberger, Johannes M. Breuss, Devesh Tewari, Judit Mihaly-Bison, Łukasz Huminiecki, Rafał R. Starzyński, Nikolay T. Tzvetkov, Jarosław Horbańczuk & Atanas G. Atanasov. (2018) Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. Biotechnology Advances 36:6, pages 1586-1607.
Crossref
Crossref
Mingxiang Ye, Yong Zhang, Hongjun Gao, Yan Xu, Pengyu Jing, Jianxiong Wu, Xinxin Zhang, Jie Xiong, Chenfang Dong, Libo Yao, Jian Zhang & Jian Zhang. (2018) Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling. Clinical Cancer Research 24:5, pages 1227-1239.
Crossref
Crossref
BAOJI SONG, HONGJIE ZHAN, QUAN BIAN & JUNPING GU. (2016) Piperlongumine inhibits gastric cancer cells via suppression of the JAK1,2/STAT3 signaling pathway. Molecular Medicine Reports 13:5, pages 4475-4480.
Crossref
Crossref
Tsung-I Hsu, Yi-Chang Wang, Chia-Yang Hung, Chun-Hui Yu, Wu-Chou Su, Wen-Chang Chang & Jan-Jong Hung. (2016) Positive feedback regulation between IL10 and EGFR promotes lung cancer formation. Oncotarget 7:15, pages 20840-20854.
Crossref
Crossref
Markus Werner & Hassan Jumaa. 2015. Molecular Biology of B Cells. Molecular Biology of B Cells
75
97
.
Jorge Martín-Pérez, José Manuel García-Martínez, María Pilar Sánchez-Bailón, Víctor Mayoral-Varo & Annarica Calcabrini. 2015. Recent Advances in Prolactin Research. Recent Advances in Prolactin Research
163
188
.
A. V. Slyvka & O. V. Okunev. (2014) Molecular mechanisms of versatile biological activity of interleukin-7. Biopolymers and Cell 30:5, pages 349-357.
Crossref
Crossref
Jana Burkhardt, Mechthild Blume, Elisabeth Petit-Teixeira, Vitor Hugo Teixeira, Anke Steiner, Elfi Quente, Grit Wolfram, Markus Scholz, Céline Pierlot, Paola Migliorini, Stefano Bombardieri, Alejandro Balsa, René Westhovens, Pilar Barrera, Timothy R. D. J. Radstake, Helena Alves, Thomas Bardin, Bernard Prum, Frank Emmrich, François Cornelis, Peter Ahnert & Holger Kirsten. (2014) Cellular Adhesion Gene SELP Is Associated with Rheumatoid Arthritis and Displays Differential Allelic Expression. PLoS ONE 9:8, pages e103872.
Crossref
Crossref
Simone Braig, Christine A. Kressirer, Johanna Liebl, Fabian Bischoff, Stefan Zahler, Laurent Meijer & Angelika M. Vollmar. (2013) Indirubin Derivative 6BIO Suppresses Metastasis. Cancer Research 73:19, pages 6004-6012.
Crossref
Crossref
E. V. Mityushova, A. N. Shatrova, V. V. Zenin, N. D. Aksenov & I. I. Marakhova. (2013) STAT5 signaling in expression of the α-subunit of interleukin-2 receptor in human blood lymphocytes. Cell and Tissue Biology 7:5, pages 397-406.
Crossref
Crossref
Roberto Coppari & Christian Bjørbæk. (2012) Leptin revisited: its mechanism of action and potential for treating diabetes. Nature Reviews Drug Discovery 11:9, pages 692-708.
Crossref
Crossref
Catia Marozzi, Fabrizio Bertoni, Elisa Randelli, Francesco Buonocore, Anna Maria Timperio & Giuseppe Scapigliati. (2012) A monoclonal antibody for the CD45 receptor in the teleost fish Dicentrarchus labrax. Developmental & Comparative Immunology 37:3-4, pages 342-353.
Crossref
Crossref
Steven A. Corfe & Christopher J. Paige. (2012) The many roles of IL-7 in B cell development; Mediator of survival, proliferation and differentiation. Seminars in Immunology 24:3, pages 198-208.
Crossref
Crossref
Laura Vera-Ramirez, Pedro Sanchez-Rovira, M. Carmen Ramirez-Tortosa, Cesar L. Ramirez-Tortosa, Sergio Granados-Principal, Jose A. Lorente & Jose L. Quiles. (2011) Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Critical Reviews in Oncology/Hematology 80:3, pages 347-368.
Crossref
Crossref
Fatemeh Safari, Naoko Murata-Kamiya, Yasuhiro Saito & Masanori Hatakeyama. (2011) Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif that is exploited by bacterial effectors. Proceedings of the National Academy of Sciences 108:36, pages 14938-14943.
Crossref
Crossref
Y Nakaya, K Shide, T Niwa, J Homan, S Sugahara, T Horio, K Kuramoto, T Kotera, H Shibayama, K Hori, H Naito & K Shimoda. (2011) Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms. Blood Cancer Journal 1:7, pages e29-e29.
Crossref
Crossref
Christina Kittipatarin, Nuska Tschammer & Annette R. Khaled. (2010) The interaction of LCK and the CD4 co-receptor alters the dose response of T-cells to interleukin-7. Immunology Letters 131:2, pages 170-181.
Crossref
Crossref
A.E. Saunders & P. Johnson. (2010) Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45. Cellular Signalling 22:3, pages 339-348.
Crossref
Crossref
Thorbjørn KrejsgaardClaudia S. Vetter-KauczokAnders WoetmannHermann KneitzKarsten W. EriksenPaola LovatoQian Zhang, Mariusz A. Wasik, Carsten GeislerElisabeth Ralfkiaer, Juergen C. BeckerNiels Ødum. (2009) Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma. Blood 113:23, pages 5896-5904.
Crossref
Crossref
Hui Jin, Nathan J. Lanning & Christin Carter-Su. (2008) JAK2, But Not Src Family Kinases, Is Required for STAT, ERK, and Akt Signaling in Response to Growth Hormone in Preadipocytes and Hepatoma Cells. Molecular Endocrinology 22:8, pages 1825-1841.
Crossref
Crossref
Roxana Pincheira, Ariel F. Castro, Osman Nidai Ozes, Prema S. Idumalla & David B. Donner. (2008) Type 1 TNF Receptor Forms a Complex with and Uses Jak2 and c-Src to Selectively Engage Signaling Pathways That Regulate Transcription Factor Activity. The Journal of Immunology 181:2, pages 1288-1298.
Crossref
Crossref
Nima M. Gharavi, Jackelyn A. Alva, Kevin P. Mouillesseaux, Chi Lai, Michael Yeh, Winnie Yeung, Jaclyn Johnson, Wan Lam Szeto, Longsheng Hong, Michael Fishbein, Lai Wei, Lawrence M. Pfeffer & Judith A. Berliner. (2007) Role of the JAK/STAT Pathway in the Regulation of Interleukin-8 Transcription by Oxidized Phospholipids in Vitro and in Atherosclerosis in Vivo. Journal of Biological Chemistry 282:43, pages 31460-31468.
Crossref
Crossref
Natasa Debeljak & Arthur Sytkowski. (2007) EpoR. AfCS-Nature Molecule Pages.
Crossref
Crossref
K A Vincent, C Jiang, I Boltje & R A Kelly. (2007) Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease. Gene Therapy 14:10, pages 781-789.
Crossref
Crossref
Lily I. PaoKaren BadourKatherine A. SiminovitchBenjamin G. Neel. (2007) Nonreceptor Protein-Tyrosine Phosphatases in Immune Cell Signaling. Annual Review of Immunology 25:1, pages 473-523.
Crossref
Crossref
Kai-zheng GONG, Hui ZHANG, Jian-hai DU & You-yi ZHANG. (2007) Crosstalk between signaling pathways of adrenoreceptors and signal transducers and activators of transcription 3 (STAT3) in heart. Acta Pharmacologica Sinica 28:2, pages 153-165.
Crossref
Crossref